• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Nitto Denko acquires all assets of Altea Therapeutics

Nitto Denko acquires all assets of Altea Therapeutics

May 17, 2012
CenterWatch Staff

Nitto Denko, a Japanese materials manufacturer, has acquired all the assets of Altea Therapeutics, a creator of transdermal drug delivery systems.

Among the assets Nitto Denko will acquire—including patents, trademarks and laboratory equipment—the company will gain Altea’s Active Transdermal Therapeutic System (TTS) technology. The delivery system, which physically enhances the skin’s ability to absorb medical compounds, will allow Nitto Denko to meet growing needs in the medical field and help improve the quality of life for patients across the globe.

In the past Nitto Denko has had great success with the development and marketing of transdermal drug delivery patches. These patches can be self-applied and allow the controlled release of medications directly into the patient's skin. Patches are able to deliver drugs into the patient's bloodstream over a prolonged period of time and at a stable release rate, thereby largely eliminating side effects and vastly improving effectiveness. Nitto Denko currently has the highest global market share for conventional transdermal drug delivery patches for asthma and angina and is seeking to advance its technologies into other conditions.

With the acquisition of Altea, Nitto Denko will now be able to offer a solution, called the PassPort System, which will allow a wider range of medications to be delivered transdermally by combining thermal micro-poration and patch technologies. With this acquisition Nitto Denko provides product opportunities in addition to traditional transdermal drug delivery technologies which provide additional convenience, safety and cost effectiveness.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing